About Oligodendrocyte-myelin glycoprotein
Oligodendrocyte-myelin glycoprotein (OMG) is a protein
from Homo sapiens identified by UniProt accession
P23515, 440 residues long.
MolForge cross-references it against 0 known binders and
83 disease associations.
Target properties
| Protein name | Oligodendrocyte-myelin glycoprotein |
| UniProt accession | P23515 |
| Gene | OMG |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (83)
Diseases linked to this target (Open Targets).
- neurofibromatosis type 1 · score 0.34
- risk-taking behaviour · score 0.28
- diet measurement · score 0.22
- feeling nervous measurement · score 0.22
- worry measurement · score 0.22
- serum gamma-glutamyl transferase measurement · score 0.22
- apolipoprotein B measurement · score 0.21
- sex hormone-binding globulin measurement · score 0.20
- low density lipoprotein cholesterol measurement · score 0.19
- total cholesterol measurement · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P23515-F1 | alphafold | PREDICTED | 66.97 | — |
Amino-acid sequence (440 residues)
MEYQILKMSL CLFILLFLTP GILCICPLQC ICTERHRHVD CSGRNLSTLP SGLQENIIHL NLSYNHFTDL HNQLTQYTNL RTLDISNNRL ESLPAHLPRS LWNMSAANNN IKLLDKSDTA YQWNLKYLDV SKNMLEKVVL IKNTLRSLEV LNLSSNKLWT VPTNMPSKLH IVDLSNNSLT QILPGTLINL TNLTHLYLHN NKFTFIPDQS FDQLFQLQEI TLYNNRWSCD HKQNITYLLK WMMETKAHVI GTPCSTQISS LKEHNMYPTP SGFTSSLFTV SGMQTVDTIN SLSVVTQPKV TKIPKQYRTK ETTFGATLSK DTTFTSTDKA FVPYPEDTST ETINSHEAAA ATLTIHLQDG MVTNTSLTSS TKSSPTPMTL SITSGMPNNF SEMPQQSTTL NLWREETTTN VKTPLPSVAN AWKVNASFLL LLNVVVMLAV
Explore Oligodendrocyte-myelin glycoprotein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets